Novo Nordisk · 10 hours ago
Internship - Field Systems (Multiple Positions)
Plainsboro, NJ
Internship
Onsite
Intern
$52K/yr - $89K/yrNovo Nordisk is a global pharmaceutical company focused on improving patient outcomes through innovative therapies for cardiometabolic diseases. The Field Systems internship offers students hands-on experience, working on projects related to Customer Relationship Management, Field Business Intelligence, and Field Training and Education, while collaborating with experienced professionals.
BiotechnologyHealth CareMedicalPharmaceutical
No H1B
Responsibilities
Working directly with the field on strategic projects
Helping with new field facing systems
Data aggregation and/or field communications
Attend internal meetings
Work on cross functional projects
See through completion no less than two-three active projects
Take on more projects depending on uptake and knowledge of the scope of the projects
Qualification
Required
Must be a current student enrolled or recently graduated (graduation date no earlier than April 2026) at/from an accredited college or university pursuing at least a bachelor's degree
Strong academic record with a preferred cumulative GPA of 3.0 or higher
Conscientious self-starter with good organizational skills, project management skills and attention to detail
Ability to balance multiple projects and priorities, must be able to multi-task
Strong interpersonal communication and ability to collaborate with teams; must effectively operate independently, across functional lines, and with internal customers
Demonstrated personal initiative, self-motivation, flexibility, adaptability and willingness to learn
Proficient in Microsoft Office Tools including Word, Excel, PowerPoint, etc
Preferred
A completed or in progress undergraduate or graduate degree in Business Administration, Marketing, Finance or a related discipline preferred
Company
Novo Nordisk
Novo Nordisk is a healthcare company that produces and distributes insulin and other diabetes drugs to treat chronic diseases.
Founded in 1923
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$22M2018-12-05Post Ipo Equity· $22M
1981-07-09IPO
Leadership Team
Lars Fruergaard Jørgensen
President and CEO
Lars Sorensen
President & CEO
Recent News
Labiotech UG
2026-01-24
bloomberglaw.com
2026-01-24
Company data provided by crunchbase